Popular Weight Loss Drugs May Pose Risks to Brain Health, Expert Warns
Neuroscience expert Dr. Tommy Wood explains that extreme caloric restriction with GLP-1 medications could lead to brain tissue shrinkage.
GLP-1 weight-loss medications, such as Ozempic and Wegovy, are gaining popularity, but experts caution that rapid weight loss and severe calorie restriction associated with these drugs could potentially deprive the brain of essential energy and nutrients.
Dr. Tommy Wood, a professor of pediatrics and neuroscience at the University of Washington, stated that the impact of these drugs on the brain is linked to the body's energy availability. He explained that the brain is the body's most energy-demanding organ.
According to Wood, the brain's reserve, which refers to the physical amount and integrity of brain tissue, operates on a bell-shaped curve relative to the body's energy availability. Excess energy from obesity, high blood sugar, and metabolic diseases can compromise brain resilience by damaging blood vessels and contributing to insulin resistance. In such cases, GLP-1 medications may offer cognitive benefits by improving blood sugar control and lowering blood pressure.
However, Wood highlighted that insufficient energy availability also poses structural risks to the brain. Because the brain relies on a consistent fuel supply, extreme calorie deficits can lead to the organ consuming its own tissue. He cited a study involving marathon runners, where brain white matter shrank during the race due to insufficient energy, illustrating the brain's tendency to decrease in size when deprived of adequate fuel. While the runners' brains recovered after rest and refueling, the example demonstrates the potential consequences of sustained energy deficiency.
Concerns about muscle loss while taking GLP-1 medications are often complex, Wood noted. Initially, some lost lean mass may be fat that had accumulated within muscles, leading to smaller muscles but not necessarily reduced strength. The quality and function of muscles might even improve in such cases. The risk, however, arises when individuals on these medications drastically reduce their food intake over extended periods. Chronic under-eating can deplete the central nervous system of vital structural nutrients, including omega-3 fatty acids, iron, and protein.
To protect brain health during weight loss, Wood recommends incorporating resistance training twice a week. This practice helps maintain functional muscle mass and can stimulate growth factors beneficial for the brain. Additionally, ensuring adequate intake of key neuro-nutrients, such as B vitamins (B12, folate, B6), vitamin D, iron, and omega-3 fatty acids, is crucial for preventing long-term cognitive impairment.
Wood advised that while these medications can be beneficial for many, it is essential not to push caloric restriction too far, ensuring the brain receives all the necessary nutrients for its optimal function.